Back
IMB
Intelligent Monitoring Group Limited
🇦🇺 ASX
🔨 COMMERCIAL SERVICES & SUPPLIES
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 231.85%
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
6
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Intelligent Monitoring Group Ltd. provides security, monitoring and risk management solutions. The company is headquartered in Perth, Western Australia. The firm is engaged in providing provision of security, monitoring and risk management services in Australia. The firm operates through three segments: Monitoring, Protective services and Service. Its Monitoring segment provides security alarm and video monitoring. Its Protective services segment provides security guarding and personnel services. Its Service segment provides alarm and video installation and maintenance services. The Company’s personal solutions include monitored security systems, intruder detection, safe at home, safe haven, high net worth family security and security response. The Company’s business solutions include business security, security and risk consultancy, monitored security systems, security personnel and case studies.
📈 Performance
Price History
+2620.00%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.68
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in IMB
6
📊 Total Capital Earnings
$3K
🔃 Average investment frequency
36 weeks
💵 Average investment amount
$1,999
⏰ Last time a customer invested in IMB
80 days
IMB investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
33%
50k - 100k
33%
Less than 50k
33%
👶 Age of investors
18 - 25
26 - 34
50%
35 - 90
50%
🙋 Legal gender of investors
Female
33%
Male
67%
Pearlers who invest in IMB also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
7.88%
📊 Share price
$110.27 AUD
💸 FINANCIALS
⛳️ DIVERSIFIED
🇦🇺 AUSTRALIA
📈 HIGH PRICE GROWTH
🧱 MATERIALS
IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
21.34%
📊 Share price
$67.73 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
DroneShield Ltd. engages in the development and commercialisation of hardware and software technology for drone detection and security. The company is headquartered in Sydney, New South Wales. The company went IPO on 2016-06-22. The company provides artificial intelligence-based platforms for protection against advanced threats, such as drones and autonomous systems. The company offers customers bespoke counter-drone (or counter-UAS) and electronic warfare solutions and off-the-shelf products designed to suit a variety of terrestrial, maritime, or airborne platforms. The Company’s products include DroneGun Tactical, DroneGun MKIII, DroneSentry, DroneSentry-C2, DroneSentry-X, RfPatrol and DroneSim among others. The DroneGun Tactical is an unmanned aerial systems (UAS) countermeasure designed for two-hand operation and long-range defeat. RfPatrol is a passive/non-emitting wearable UAS detection device. The Company’s capabilities include C-UAS, C-UxS Training, and Electronic Warfare.
🙌 Performance (5Yr p.a)
568.29%
📊 Share price
$6.03 AUD
🚀 AEROSPACE & DEFENSE
Alligator Energy Ltd. engages in the exploration and evaluation of uranium and other energy minerals. The company is headquartered in Brisbane, Queensland. The company went IPO on 2011-02-02. The firm's projects include Samphire, Big Lake, Alligator Rivers (ARUP), and Piedmont. The Samphire Project is located 20 kilometers (km) south of Whyalla in regional South Australia. Samphire comprises two uranium historical prospects (Blackbush and Plumbush). The firm owns 100% of the Big Lake Uranium Project in the Cooper Basin, South Australia, a project targeting discovery of Australia’s next in situ recovery (ISR) uranium field. The Alligator Rivers Uranium Province contains multiple uranium targets, which include the Caramal uranium resource bearing 6.5 million pounds of uranium at a high-grade of 3,100 parts per million. The Piedmont Project comprises five licenses in Northern Italy, with the Company in joint venture for four of these, focused on a 30km strike zone with multiple historic Nickel-Copper-Cobalt mines.
🙌 Performance (5Yr p.a)
81.82%
📊 Share price
$0.03 AUD
⚡️ ENERGY
CSL
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 32,065 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.
🙌 Performance (5Yr p.a)
-6.00%
📊 Share price
$208.75 AUD
🕊️ SOCIALLY AWARE
🧬 BIOTECHNOLOGY
⚖️ HIGH GOVERNANCE
Want more shares? Try these...